612435

Ranbaxy Inc. — FEI 3003476632

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 29, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Princeton, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures